$RAIZ4 Raizen's $12.6 Billion Restructuring Is Not a Resolution - It's an Equity Wipeout

Raizen reached a $12.6 billion debt restructuring deal. That's the headline. The part the headline doesn't tell you: creditors are asking for up to 90% of the company's equity in exchange for converting just 45% of the debt. If this plan clears, existing shareholders like Cosan and Shell could own virtually nothing in what they've built.

This is not a resolution story. It's a capital structure liquidation - and the market already knows it. RAIZ4 is trading at R$0.40, down 80% from its 52-week high of R$2.03. The stock has been pricing in the endgame for months. The question now isn't whether shareholders get hurt. It's whether anything of value survives for anyone.

Here's the mechanism behind the disconnect between the headline and the reality.

1. The equity swap math is the real story - not the debt number.

Raizen presented creditors with a plan to restructure roughly R$65.1 billion ($12.6 billion) in unsecured debt out of court. The conversion terms are what matter: 45% of the debt becomes equity, but creditors want that equity stake to represent up to 90% of the post-restructuring company. In plain English, bondholders are negotiating to seize control. Existing shareholders face dilution so severe it borders on total erasure. Creditors and shareholders have been negotiating since March and were described as nearing an agreement in mid-May, but the final ratio hasn't been locked. That ambiguity is itself the risk - if the 90% figure holds, today's shareholders may hold paper worth fractions of a cent.

2. The underlying business is still a R$11 billion EBITDA machine.

This is where the contrarian math starts. Raizen is Brazil's largest producer of sugar and ethanol and a major fuel distributor. In the third quarter of the 2025/26 crop year - a drought-impacted quarter that saw processed cane volumes drop - the company still generated R$60.4 billion in net revenue. Fitch forecasts EBITDA of R$10.9 billion for fiscal 2026. That level of earnings power, even in a compressed cycle, is a going-concern asset. If you can buy a claim on R$11 billion of annual operating cash flow for R$550 million - the current market cap - the valuation is not just cheap. It's absurdly cheap. The reason it's that cheap is obvious: nobody knows how much equity will survive.

3. The Argentina sale is the one bright spot - and it arrives at the right time.

On June 4, Raizen announced it will sell its Argentina downstream business to Mercuria for $1.42 billion. The deal includes the Dock Sud refinery near Buenos Aires and an extensive retail network. This matters for two reasons. First, it injects real cash into the restructuring - cash that reduces the total capital shortfall creditors are trying to fill through equity grabs. Second, it signals the new management team (likely Shell-backed) is already executing a portfolio rationalization plan. Stripping non-core assets to fund the Brazil core is exactly what you want to see from a company coming out of debt distress.

4. Shell's position is the wildcard.

Shell and Cosan are the co-owners of Raizen. Rescue talks between them collapsed in early March after they failed to agree on capital terms. But Shell is now described as backing the restructuring plan, having proposed a larger capital injection than Cosan was willing to commit. The dynamic is clear: Shell wants to keep a platform in Brazilian biofuels and fuel distribution; it's willing to write checks that preserve something. Whether that "something" is a meaningful equity stake or a small token position is the open question. Shell's track record is to fight for its capital - when they back a restructuring, there's usually a thesis behind it.

5. The timing is the remaining risk.

The restructuring plan needed to be formally filed by June 8. Creditors began evaluating the plan on June 3. Whether it clears that deadline, and what the final equity conversion ratio is, determines everything. The Fitch downgrade to "C" in March - essentially a default rating - tells you the bond market has already written off most of the debt's value. If the final terms are less brutal than the 90% creditor demand suggests, there may be a sliver of recoverable value for equity. If they're exactly as reported, existing shares may be worthless.

The break condition is simple: the final restructuring terms. Once the equity conversion ratio is locked and the post-restructuring share count is known, the math either works or it doesn't. If the rebuilt entity generates R$11 billion of EBITDA and the surviving equity trades at even 3x EBITDA - a distressed multiple - the implied value is R$33 billion. If existing shareholders retain 10% of that, the current R$550 million market cap is deeply mispriced. If they retain 1%, it isn't.

This isn't a buy today. It's a watch. The stock needs the restructuring to close and the equity math to be revealed. But the underlying disconnect is real: you're watching a R$11 billion EBITDA business trade as if it's heading to liquidation, not restructuring. That gap is where the opportunity lives - if anything survives for equity holders on the other side.